Form 4: Amgen EVP David M. Reese Reports Stock Disposal

Executive Vice President and Chief Technology Officer of Amgen, David M. Reese, reports the disposal of 3,635 shares of common stock to cover tax obligations.

Summary

• On March 17, 2025, David M. Reese, EVP & Chief Technology Officer of Amgen Inc., reported a transaction involving Amgen's common stock.
• Reese disposed of 3,635 shares at a price of $313.71 per share.
• This transaction resulted in Reese owning 40,702 shares of Amgen common stock following the reported transaction.
• The disposal was related to covering tax obligations.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing simply reports a transaction related to tax obligations, which is a common occurrence.

Industry Context

Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company executives and their potential impact on the stock's performance.

Stakeholder Impact

• The disposal of shares by an executive could have a minor impact on shareholder sentiment, but is unlikely to be significant given the routine nature of the transaction.

Key Dates

Keywords

Form 4, Amgen, AMGN, David M. Reese, Stock Disposal, EVP, Chief Technology Officer, Beneficial Ownership, Tax Obligations